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ABSTRACT 
The  paper  reviews  mechanisms  underlying  autonomic  disorders,  with  a  focus  on  cardiovascular  dysfunction. 
Neurosurgical approaches are described for medically refractory hypertension and orthostatic hypotension. After review 
of  microvascular  decompression  of  the  rostral  ventrolateral  medulla,  stereotactic  CT  and  MRI  guided  deep  brain 
stimulation of the periaqueductal grey matter (PAG) is evaluated. Results are presented from patient studies showing 
reductions in blood pressure with ventral PAG stimulation and increases in blood pressure with dorsal PAG stimulation. 
A rationale for the treatment of autonomic disorders by neurosurgical intervention is discussed. © 2007 Biomedical 
Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
The  autonomic  nervous  system  comprises 
segregated  and  differentially  regulated  neuronal 
pathways  linking  the  central  nervous  system  with 
endocrine glands, smooth muscle and visceral organs via 
central  neuron  groups  and  peripheral  ganglia  [1,  2]. 
Disorders  of  autonomic  function  give  rise  to 
cardiovascular,  gastrointestinal,  genitourinary  and 
endocrine disturbances [3]. Such disturbances are often 
poorly understood and
 managed, one reason being that 
autonomic
 dysfunction spans several medical specialties 
and  requires  a  strong  conceptual  understanding  of 
physiology  and  anatomy.  The  interpretation  of 
autonomic investigations is frequently challenging.  
Of  the  autonomic  disorders,  alongside  the 
neuropathic  complications  of  diabetes  mellitus,  the 
cardiovascular disorders of hypertension and orthostatic 
hypotension  refractory  to  medical  treatment  present  a 
considerable  disease  burden  with  high  associated 
morbidity  and  mortality.  Up  to  27%  of  hypertensive 
people have poorly controlled blood pressure [4]. 3% are 
refractory to pharmacotherapy [5], and are therefore at 
considerably increased risk of both cerebrovascular and 
cardiovascular adverse events [6, 7]. A wealth of animal 
literature  depicts  brainstem  regions  in  cardiovascular 
function  ranging  from  demonstrations  of  neurogenic 
shock secondary to infrapontine transection by Dittmar 
in the 1870s and the later elucidation of its sympathetic 
vasomotor  component  [8].  In  particular  the  rostral 
ventral medulla, adjacent vagus and periaqueductal grey 
matter  are  potential  targets  for  therapy  for  such 
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autonomic  disorders.  Advances  made  towards 
understanding  these  autonomic  disorders  and  their 
treatment using neurosurgical interventions and imaging 
adjuncts are described here. 
MICROVASCULAR DECOMPRESSION OF THE ROSTRAL 
VENTROLATERAL MEDULLA 
A  rationale  for  intracranial  intervention  to  treat 
medically  refractory  hypertension  developed  from  the 
hypothesis that exerting pressure upon cranial nerves by 
ectatic  perimesencephalic  vasculature  could  result  in 
cranial nerve palsies. Cranial nerve dysfunction could be 
ameliorated  by  retromastoid  craniectomy  and 
microvascular decompression of the posterior fossa [9, 
10].  Contentious  at  first  [11],  the  procedure  became 
established  in  the  past  two  decades  as  the  surgical 
therapy  of  choice  for  trigeminal  neuralgia  and  for  the 
relief  of  hemifacial  spasm  and  glossopharyngeal 
neuralgia  [12].  Many  patients  hypertensive  prior  to 
surgery  exhibited  vascular  compression  of  the  rostral 
ventrolateral  medulla  (RVLM)  and  adjacent  dorsal 
glossopharyngeal and vagal nerve roots, with subsequent 
normotension achieved in several patients in whom such 
compression was relieved [13, 14]. 
Neurosurgery  has  been  transformed  by  the 
introduction of the operating microscope and endoscopes 
have  proven  advantageous  in  minimizing  the 
invasiveness  of  microvascular  decompression  [15,  16]. 
Moreover, advances in imaging have contributed to the 
clinical  assessment  of  symptomatology  suggestive  of 
putative  perimesencephalic  neurovascular  compression 
syndromes.  Magnetic  resonance  angiography  (MRA) 
often  detects  a  problem  [17 19],  with  high  resolution 
magnetic  resonance  imaging  (MRI)  methodologies 
promising  to  advance  diagnosis  [20 22].  However, 
current MRI technology remains unable to consistently 
detect compression amenable to surgery [23 25]. 
The results of microvascular decompression of the 
glossopharyngeal and vagal cranial nerves for medically 
refractory hypertension suggest that one third to one half 
of patients show a sustained, long term improvement [26, 
27]. Neurosurgery for hypertension is predicated first if 
the hypertension is severe and medically refractory and 
second  if  the  hypertension  is  not  due  to  renal  or 
endocrine  abnormalities  such  as  phaeochromocytoma, 
that is to say ‘essential’ in nature. The corollary therefore 
is that essential hypertension is neurogenic in origin. 
The  theoretical  argument  for  microvascular 
decompression is that the RVLM is not only a centre for 
cardiovascular  control,  but  vagal  afferents  from  the 
myocardium  to  the  nucleus  of  the  solitary  tract  pass 
preferentially  along  the  left  aspect  of  the  RVLM  and 
therefore the sympathetic tone and cardiac contractility 
are  particularly  sensitive  to  prolonged  pulsatile 
compression of this region. The argument is borne out by 
elegant animal models [28 30] and other contributors to 
hypertension  can  be  explained  within  the  model:  for 
example, age and atherosclerosis are causes of vascular 
ectasia  with  reduced  mural  compliance.  However  the 
results of the small surgical case series conducted thus 
far  remain  equivocal.  Larger  controlled  trials  with 
confirmatory pre  and post operative imaging and post 
mortem  evidence  are  required  to  confirm  both  the 
benefits and mechanism. 
DEEP BRAIN STIMULATION OF THE PERIAQUEDUCTAL 
GREY MATTER 
The periaqueductal grey area (PAG) is established 
as a region important to the modulation of pain. It has 
been targeted by deep brain stimulating electrodes for the 
treatment  of  chronic,  intractable  neuropathic  pain  for 
three  decades  [31 34].  In  mammals,  the  region  is 
instrumental  in  ‘defence’  reactions  [35],  integrating 
descending  responses  from  forebrain  to  cardiovascular 
effector  organs  to  assist  survival  by  modulating  active 
sympathetic  ‘fight’and  ‘flight’  or  passive  ‘fear’  and 
‘withdrawal’ responses [36 38]. Whether the coping is 
active  or  passive  seems  to  determine  whether  the 
sympathetic response is pressor or hypotensive and the 
concomitant analgesia opioid or non opioid mediated in 
animals  [39].  Electrical  stimulation  of  the  PAG  in 
animals  elicits  such  defence  reactions,  dorsal  regions 
being  associated  with  active  coping  and  hypertensive 
effects  and  ventral  regions  with  passive  coping  and 
hypotensive  effects  [40 42].  Thus,  it  is  likely  that 
stimulation of the same area in the human will affect not 
only pain modulation pathways, but also other autonomic 
pathways  including  those  affecting  cardiovascular 
function. The PAG receives ascending projections from 
the RVLM [43], and much animal evidence implicates it 
in  cardiovascular  control  [44,  45],  pioneering 
demonstrations  having  been  conducted  in  felines  [46]. 
Additionally, the neurosurgical treatment of deep brain 
stimulation  for  pain  enables  the  study  of  such 
cardiovascular effects in humans. 
The technique of deep brain stimulation is an image 
guided  stereotactic  neurosurgical  intervention. 
Techniques  vary  between  neurosurgical  centres.  Our 
technique is briefly outlined here. After a pre operative 
T 1 weighted MRI scan, a Cosman Roberts Wells base 
ring  is  applied  to  the  patient’s  head  under  local 
anaesthesia.  A  stereotactic  computerised  tomography 
(CT)  scan  is  then  performed  and  the  MRI  scan  is 
volumetrically fused to it using Radionics Image Fusion
® 
and Stereoplan
® programs to eliminate spatial distortions 
that arise from magnetic field effects [47, 48]. The co 
ordinates  for  the  PAG  and  entry  trajectory  are  then 
calculated.  A  frontal  trajectory  avoiding  the  lateral 
ventricles  is  preferred.  Targets  are  contralateral  to  the 
painful  side  of  the  body.  After  a  parasagittal  scalp 
incision and separate 2.7 mm twist drill craniotomy, the 
PAG is implanted with a Medtronic™ 3387 quadripolar 
electrode.  The  electrode  is  fixed  to  the  skull  by  a 
miniplate and it is externalised parietally via temporary 
extensions.  After  surgery,  a  further  stereotactic  CT  is 
performed  and  co registered  as  before  to  confirm 
electrode  position.  After  a  week  of  post operative 
assessment, a decision is made whether to permanently 
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implant the electrode in a second operation under general 
anaesthesia.  It  is  connected  to  a  pulse  generator 
implanted  subcutaneously,  usually  infraclavicularly  in 
subcutaneous  facia.  Our  surgical  technique  is  detailed 
further elsewhere [33, 49, 50]. 
Preliminary  evidence  has  associated  efficacious 
PAG analgesia using deep brain stimulation in humans 
with  hypertensive  and  chronotropic  cardiovascular 
effects  [51,  52].  Our  recent  research  has  delineated  in 
greater  detail  the  cardiovascular  effects  of  PAG  deep 
brain  stimulation  [53 55].  The  results  are  summarised 
here. 
ALTERING BLOOD PRESSURE BY DEEP BRAIN 
STIMULATION 
We  have  shown  that  electrical  stimulation  of  the 
human PAG alters blood pressure [55]. In this study of 
fifteen chronic neuropathic pain patients (17 electrodes), 
blood  pressure  and  heart  rate  (via  electrocardiogram) 
were continuously measured in the laboratory while deep 
brain stimulation parameters were altered from 10 Hz to 
50  Hz  (analgesic  frequencies)  [50].  We  found  that 
cardiovascular responses to stimulation were consistent, 
as measured on at least three occasions, for any pair of 
electrode contacts used. Arterial blood pressure reduced 
significantly overall in seven pairs of electrode contacts 
in seven patients. Conversely, blood pressure increased 
significantly  in  six  pairs  of  contacts  in  six  patients 
(p<0.05, ANOVA; Figure 1).  
For the subjects with reductions in blood pressure, 
the  average  reduction  was  14.2±3.6  mmHg  (range  7 
25mmHg),  or  13.9%,  after  300  seconds  stimulation. 
Figure 1a shows the drop in systolic blood pressure (SBP) 
accompanied  by  a  fall  in  diastolic  BP  (DBP)  of 
4.9mmHg  ±  2.9  (p=0.03,  single  factor  ANOVA,  n=7, 
range  1.5 9.3),  equivalent  to  6%.  This  implicates  a 
vasodilatatory mechanism. However, the greater systolic 
reduction  with  consequently  reduced  pulse  pressure 
suggests additional central cardiovascular influences. We 
therefore  measured  the  change  of  SBP  with  time 
(maximum dP/dt, i.e., the gradient of the blood pressure 
curve), a known marker of cardiac contractility [56]. The 
measures  revealed  a  mean  reduction  of  222  mmHg/s 
±126 (19.8%, p=0.06), suggestive of reduced myocardial 
contractility. In contrast, the R R interval, a measure of 
heart  rate,  remained  largely  unchanged  throughout  the 
stimulation period (mean change = 0.01s ±0.04, range 0 
0.08).  As  heart  rate  is  controlled  via  the  vagus,  this 
implies no vagally mediated parasympathetic changes. 
For  those  subjects  experiencing  increased  blood 
pressure,  the  mean  rise  in  SBP  was  16.7  mmHg  ±5.9 
(p<0.001,  single  factor  ANOVA,  n=6,  range  16 
31mmHg),  equivalent  to  16.4%  at  the  end  of  a  400s 
period where stimulation was started at 100s. Identical 
stimulation parameters of frequency 10 Hz, pulse width 
120  s and up to 3V amplitude both raised and lowered 
blood pressure in different contact pairs. As with blood 
pressure  reduction,  increases  were  accompanied  by  a 
smaller rise in DBP of 4.9mmHg ±2.8 or 6.4% (p=0.04, 
single factor ANOVA, n=6, range = 2.4 to 12.1mmHg). 
An increase in mean pulse pressure was also observed. 
Maximum dP/dt increased by 212±97 mmHg/s (p<0.03, 
single factor ANOVA). As for blood pressure reduction, 
the R R interval did not change changed. Thus pressor 
and  hypotensive  related  cardiac  effects  of  stimulation 
appear to mirror each other. 
Six control patients with implanted neurostimulatory 
interventions were investigated (six thalamic electrodes, 
one  spinal  cord  stimulator).  Despite  extensive 
investigation  using  multifarious  frequencies,  pulse 
widths and voltages, and a variety of electrode contact 
configurations,  we  were  unable  to  alter  their  blood 
pressure  significantly.  In  addition  to  the  control 
electrodes  without  cardiovascular  effect,  four  patients 
with PAG electrodes (six electrodes in total) also failed 
to exhibit blood pressure changes. 
Because  blood  pressure  changes  in  animals  vary 
depending on whether the electrode is in ventral or dorsal 
PAG, electrode position was assessed. Electrodes were 
plotted on a brain atlas [57] using the post operative MRI 
and a manipulation program (MRIcro version 1.38 build 
1,  Chris  Rorden).  Those  electrodes  that  reduced  blood 
pressure were placed ventrally and those that increased 
blood  pressure  dorsally  (Figure  2).  Of  the  patients 
without  blood  pressure  changes,  four  of  the  five 
electrodes available for plotting were dorsal to the group 
that raised BP and hence probably beyond the PAG. The 
remaining electrode was in mid periventricular grey.  
Comparing changes in blood pressure between the 
two  groups  of  patients  with  ventrally  and  dorsally 
situated electrodes (n=8 and n=9 respectively) including 
those without significant changes, the mean peak change 
in SBP was  10.3±2.8 mmHg for the ventral group and 
+10.8±3.1  mmHg  for  the  dorsal  group  (p=0.003,  one 
way ANOVA). Similarly, the mean peak change in DBP 
was  4.6±1.2 mmHg and +3.5±0.8 mmHg respectively 
(p=0.007).  Mean  peak  change  in  pulse  pressure  was   
8.6±3.5 mmHg for the ventral and +7.4±2.1 mmHg for 
the dorsal group (p=0.01). dP/dt changes were  181.6±28 
mmHg/s  for  ventral  and  82±26  mmHg/s  for  dorsal 
electrode groups (p=0.007). Comparison of RR intervals 
between  the  two  groups  did  not  reveal  significant 
differences (p=0.13). 
Analysis of the dominant frequencies in the blood 
pressure wave form clarifies the underlying mechanisms 
of blood pressure changes [58]. Mayer’s wave (<0.1 Hz) 
suggests sympathetic autonomic control [59, 60]. Using 
autoregressive  power  spectral  analysis  [61]  blood 
pressure  changes  were  associated  with  alterations  in 
sympathetic  tone  (Figure  3a).  For  group  results, 
logarithms of the power of the low and high frequency 
components as the integral of the power spectra between 
0.05  and  0.15Hz  and  between  0.15  and  0.4Hz  were 
calculated for each of the increased and decreased blood 
pressure groups on and off stimulation with significance 
testing  using  a  paired  t test  (Figures  3c  and  3d).  The 
results showed significant low frequency power spectra 
changes corresponding to blood pressure changes. 
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FROM AUTONOMIC MICROVASCULAR NEUROSURGERY 
TO AUTONOMIC FUNCTIONAL NERUOSURGERY 
We have demonstrated that it is possible to increase 
or  decrease  blood  pressure  in  humans  with  electrical 
stimulation  of  the  PAG.  Furthermore,  the  direction  of 
blood pressure change can be controlled by placing the 
electrode  in  either  ventral  or  dorsal  PAG.  Reducing 
blood  pressure  with  deep  brain  stimulation  is 
theoretically possible but in itself poses a risk. Whereas 
DBS  surgery  entails  a  0.3%  stroke  risk  and  is  not 
inexpensive [62, 63], the changes shown augur well for 
its  potential  utility  in  the  treatment  of  medically 
refractory  hypertension.  Further  research  requires 
demonstration of a sustained effect in addition to further 
elucidation  of  mechanisms  of  action.  Moreover,  for 
microvascular  decompression  which  carries  risks  of 
cerebrospinal  fluid  leak  (1.9%),  deafness  (0.8%)  and 
cerebellar damage (0.4%) [25], the procedural risks need 
to  be  reduced  before  the  procedure  is  applied  to 
prophylaxis of hypertension rather than treatment of an 
established  disability  such  as  stroke  [33,  64].  Future 
advances in stimulator technology may yield such risk 
reductions. The future potential of deep brain stimulators 
whose  parameters  adapt  to  control  changing  pain  or 
degree of blood pressure abnormality also make such an 
intervention appealing [65, 66]. 
The demonstration that PAG deep brain stimulation 
can  increase  and  decrease  blood  pressure  raises  the 
possibility that orthostatic or postural hypotension might 
be  treatable  by  neurosurgery.  In  the  normal  subject, 
assumption  of  an  upright  posture  leads  to  pooling  of 
venous  blood  in  the  lower  extremities  and  splanchnic 
circulation. The resulting decrease in venous return to the 
heart  leads  to  a  compensatory,  centrally  mediated 
increase in sympathetic and decrease in parasympathetic 
activity (known as the baroreceptor reflex). Such activity 
normally causes a transient fall in SBP (5 to 10mmHg) a 
small rise in DBP (5 to 10mmHg) and a rise in heart rate 
of  10 25  beats  per  minute.  In  orthostatic  hypotension, 
patients  suffer  troublesome  low  blood  pressure  on 
standing  or  symptoms  of  cerebral  hypoperfusion  [67]. 
Occuring in up to a fifth of people over 65 years of age, 
its  treatment  may  lead  to  troublesome  raised  blood 
pressure  [68,  69].  The  presented  evidence  for  pressor 
effects  of  dorsal  PAG  stimulation  together  with 
supportive animal experiments showing baroreflex vagal 
bradycardia  inhibition  with  stimulation  in  rats  [70] 
suggest  that  such  stimulation  could  influence  the 
baroreceptor reflex. Our human studies support such a 
theory  [53].  Eleven  patients  including  one  with 
orthostatic  hypotension  resolved  with  PAG  deep  brain 
stimulation  and  five  with  mild  orthostatic  intolerance 
(MOI; a fall in systolic blood pressure of >20mmHg on 
standing,  but  no  clinical  symptoms)  demonstrated 
significant reductions in postural drops in blood pressure 
(p<0.001,  t test;  Figures  4a  and  4b)  compared  to  a 
control group  without postural blood pressure changed 
(Figure 4c). 
Assessing  baroreflex  sensitivity  gives  insight  into 
the mechanisms underlying postural changes. In healthy 
subjects, baroreflex sensitivity decreases on standing [71, 
72]. In autonomic neuropathy, such as that of diabetes, it 
has been shown that it is lower in the supine position 
with  a  diminished  reduction  on  standing  compared  to 
normal  subjects  [72].  Calculating  the  baroreflex 
sensitivity  index  from  the  transfer  function  of  systolic 
blood  pressure  and  RR  interval  signals  using  bivariate 
autoregressive  modelling  [73],  we  showed  that  the 
baroreflex  sensitivity  in  the  subject  with  orthostatic 
hypotension  and  the  group  with  MOI  were  similar  to 
those with a mild autonomic neuropathy (table 1). We 
also  showed  that  stimulation  significantly  raised 
sensitivity in the sitting position (t test, p=0.018, <0.001 
and  0.002  for  subject  #1,  MOI  and  non MOI  groups 
respectively) and reduced the magnitude of reduction on 
standing in orthostatic hypotension (p=0.024 subject #1, 
p<0.001  MOI).  This  suggests  that  the  postural  blood 
pressure changes reversed by deep brain stimulation of 
the dorsal PAG act via a central mechanism to increase 
baroreceptor sensitivity. 
CONCLUSIONS 
Neurosurgery  for  the  treatment  of  autonomic 
disorders  has  thus  far  embraced  two  approaches.  The 
first,  posterior  fossa  decompression  of  the  left  RVLM 
utilising  microscopy  and  also  endoscopy  has  shown 
some sustained benefit in small case series and has been 
vindicated  to  some  extent  by  MRA  findings  of 
perimesencephalic vascular compression as a risk factor 
for  hypertension  [74].  However,  further  controlled 
studies  in  larger  samples  of  patients  are  required  to 
confirm its benefit, and its extension to the amelioration 
of  acquired  diabetes  mellitus  appears questionable  and 
less robustly supported by radiological evidence [74, 75]. 
The  second  functional  neurosurgical  approach, 
utilising sterotaxy, CT, MRI and deep brain stimulation 
technology has demonstrated blood pressure changes in 
an  intensively  studied  group  of  patients  treated  by 
electrodes  in  their  midbrain  PAG  for  chronic  pain. 
Repeatable  changes  in  blood  pressure  dependant  upon 
whether an electrode is in ventral or dorsal PAG have 
been  demonstrated,  albeit  over  short  periods  of  time. 
Theoretical  foundations  for  the  treatment  of  both 
essential hypertension and orthostatic hypotension have 
been derived from the results presented. 
Both  interventions  are  exciting  not  only  because 
they  translate  research  directly  from  animal  models  to 
humans but because of their vivid illustration of potential 
clinical therapies. Essential hypertension treated without 
drugs  appeals  because  their  adverse  effects  would  be 
avoided.  Similarly,  drug  treatment  of  orthostatic 
hypotension cannot differentiate between the supine and 
standing positions and may therefore lead to nocturnal 
hypertension [68, 69], a predicament potentially resolved 
by  demand  driven  or  posturally  sensitive  deep  brain 
stimulators.  A  myriad  of  related  and  difficult  to  treat 
autonomic  syndromes,  for  example  orthostatic 
hypertension  [76],  may  also  respond  to  neural 
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stimulation of central autonomic brain centres. Parallel 
advances  in  both  the  interventions  themselves  and  the 
imaging  modalities  they  utilise  will  enable  greater 
understanding  of  autonomic  dysfunction  and  lead  to 
definitive and effective treatment. After these promising 
research driven  beginnings,  autonomic  neurosurgery 
should demonstrate long term efficacy in larger samples 
of  patients  and  favourable  cost benefit  over  lifelong 
medication before it becomes the treatment of choice for 
such disorders. 
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Table 1  Changes in Heart Rate Variability and Baroreflex sensitivity while sitting and standing, with stimulation 
on  or  off.  MOI=  mild  orthostatic  intolerance.  Ranges  shown  in  brackets.  *indicates  significant 
difference between Off and On conditions within each group 
  Group:  Subject #1  MOI group  Non MOI group 
  Stimulation:  OFF  ON  OFF  ON  OFF  ON 
Low Frequency (ms2)             
  Sitting    5.2     4.7     69.8 (1 285)  136.2* (1 474)  208.1 (81 330)  466.3* (298 489) 
  Standing    1.6     4.9       7.0 (0.1 20)  135.0* (1 520)  313.5 (63 603)  346.9* (86 636) 
High Frequency (ms2)             
  Sitting    6.9     7.4   176.0 (3 730)  182.1   (1 757)  224.6 (10 618)  341.4   (9 727) 
  Standing    4.2     7.6   122.4 (1 600)  181.8* (1 751)  247.5 (6 521)  464.6* (5 1280) 
Baroreflex sensitivity  
index (ms/mmHg) 
           
  Sit    3.6  11.1      6.6 (2.5 10.7)      8.6* (7.2 11.1)      9.9 (2.9 17.3)    15.3* (6.9 23.8) 
  Stand    0.13    5.41      0.7 (0.1 2)      4.3* (0.5 9.2)      4.5 (0.1 8.3)    14.7* (4.2 26) 
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Figure 1  (a)  Changes  in  cardiovascular parameters  associated  with  reduced blood pressure.  Patterned  area  = 
period of stimulation. Grey area = ± one standard error of the mean. SBP= systolic blood pressure, 
DBP= diastolic blood pressure. PP= pulse pressure, RR interval= time period between R waves on 
electrocardiogram, dP/dt = change of systolic blood pressure with time. (b)  Changes in cardiovascular 
parameters associated with increased blood pressure. (see text for details). 
 
 
 
 
 
Figure 2  (a) Sagittal positions of the electrodes in patients in whom there were changes in blood pressure. (b) 
Coronal positions. For clarity, patients with no changes are not shown. Note that patient’s #1 7 all had 
reduction in BP (black contacts) and are the most ventral electrodes. Conversely, #8 11 and the upper 2 
contacts  of  #1  and  #6  had  a  rise  in  BP  (patterned  contacts).  Gray  contacts  are  those  that,  when 
stimulated,  had  no  effect  on  BP.  AC=anterior  commissure,  PC=posterior  commissure, 
PVG=periventricular  gray,  PAG=periaqueductal  gray,  SC=superior  colliculus  (the  level  of  which  is 
depicted by the dotted circle in 1B), RN=red nucleus, III=third ventricle, Aq=aqueduct. Inset of  A 
shows the ACPC plane, inset of B shows the slice position. 
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Figure 3  (a) Changes in low and high frequency power spectra of systolic blood pressure. A. Example in one 
patient, in whom blood pressure could be increased or decreased, depending on which contacts were 
used. A change in the low frequency component was associated with change in blood pressure, implying 
changes in sympathetic nervous system activity. (b,c) Changes for the groups in whom blood pressure 
decreased (N=7) or increased (N=6) respectively. Error bars denote ±one SEM. 
 
 
Figure 4  Blood Pressure and Heart Rate changes on standing. a c: mean changes in systolic blood pressure for 
subject #1, MOI group, and non OI group respectively. d f: changes in heart rate for the same groups. 
All  traces  include  the  mean  of  three  sessions,  averaged  every  ten  seconds.  MOI=  mild  orthostatic 
intolerance  group, non OI  =  no  orthostatic  intolerance  group.  Grey  area= period  when patient  was 
sitting, white area (from 0 seconds) = period of standing. ■ = stimulation ‘off’, □ = stimulation ‘on’. 
Error bars show ± one standard error of the mean. 
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